IGIC UK CEO awarded shares under ESPP

International General Insurance Holdings Ltd. executive Andreas Costas Loucaides, CEO of IGI UK, reported routine equity compensation activity.

Rhea-AI Filing Summary

International General Insurance Holdings Ltd. executive Andreas Costas Loucaides, CEO of IGI UK, reported routine equity compensation activity. On July 7, 2026, he acquired 22 common shares through the U.K. Employee Stock Purchase Plan at $27.5167 per share and received an additional 22 matching common shares at no cost under the same plan.

The matching shares are scheduled to vest in full on July 7, 2027, subject to his continued service. All reported shares are held directly for his benefit, apart from 121 unvested ESPP shares that are held in an employee trust.

Insider Trade Summary

Grant/Award: 44 shares

Grant/Award 2 txns

Insider Loucaides Andreas Costas

Role CEO, IGI UK

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	22	$27.5167	$605.37
Grant/Award	Common Shares	22	$0.00	$0.00

Holdings After Transaction: Common Shares — 37,932 shares (Direct)

Footnotes (3)

1. F1. Represents common shares purchased by the Reporting Person pursuant to the U.K. Employee Stock Purchase Plan (the "ESPP").
2. F2. Represents an award of matching common shares under the ESPP that will be eligible to vest in full on July 7, 2027, subject to the Reporting Person's continued service through such date.
3. F3. All of the shares reported are held directly by the Reporting Person, except for 121 of the unvested ESPP shares which are held in an employee trust for the benefit of the Reporting Person.

Key Figures

ESPP purchase shares: 22 shares ESPP purchase price: $27.5167 per share Matching award shares: 22 shares +1 more

4 metrics

ESPP purchase shares 22 shares Common shares purchased under U.K. ESPP on July 7, 2026

ESPP purchase price $27.5167 per share Price paid for 22 ESPP shares on July 7, 2026

Matching award shares 22 shares Matching common shares awarded under ESPP, vesting July 7, 2027

Unvested ESPP shares in trust 121 shares Unvested ESPP shares held in employee trust for reporting person

Key Terms

U.K. Employee Stock Purchase Plan, ESPP, matching common shares, employee trust

4 terms

U.K. Employee Stock Purchase Plan financial

"Represents common shares purchased by the Reporting Person pursuant to the U.K. Employee Stock Purchase Plan"

ESPP financial

"pursuant to the U.K. Employee Stock Purchase Plan (the "ESPP")."

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

matching common shares financial

"Represents an award of matching common shares under the ESPP"

employee trust financial

"121 of the unvested ESPP shares which are held in an employee trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IGIC executive Andreas Costas Loucaides report?

Andreas Costas Loucaides reported acquiring IGIC common shares through an employee stock purchase plan. He bought 22 shares at $27.5167 each and received 22 matching shares, reflecting routine compensation-related equity participation rather than an open-market trade.

How many IGIC shares did the IGI UK CEO obtain in this Form 4 filing?

The IGI UK CEO obtained a total of 44 IGIC common shares. He purchased 22 shares under the U.K. Employee Stock Purchase Plan and received an additional 22 matching shares awarded under the same plan, subject to future vesting conditions tied to continued service.

What price did Andreas Costas Loucaides pay for the IGIC shares he purchased?

He purchased 22 IGIC common shares at a price of $27.5167 per share. This acquisition occurred under the U.K. Employee Stock Purchase Plan, which allows eligible employees to buy company stock through a structured program rather than regular market purchases.

What are the vesting terms for the matching IGIC shares in this Form 4?

The 22 matching IGIC common shares are scheduled to vest in full on July 7, 2027. Vesting is conditioned on Andreas Costas Loucaides’ continued service through that date, meaning he must remain employed to receive full ownership of those awarded shares.

How are the ESPP-related IGIC shares held for Andreas Costas Loucaides?

All shares reported are held directly for Andreas Costas Loucaides’ benefit, with one exception. The filing notes that 121 unvested ESPP shares are held in an employee trust for his benefit, reflecting a structured holding arrangement common in share-based compensation plans.

Does this IGIC Form 4 indicate open-market buying or a compensation grant?

The Form 4 reflects compensation-related equity participation, not an open-market buy. Shares were acquired and matched under the U.K. Employee Stock Purchase Plan, indicating a structured employee program rather than discretionary trading in IGIC stock on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/09/2026 - 04:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Loucaides Andreas Costas

(Last) (First) (Middle)

20 FENCHURCH STREET, FLOOR 15

(Street)

LONDON EC3M 3BY

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
International General Insurance Holdings Ltd. [ IGIC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, IGI UK

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	07/07/2026		A		22(1)	A	$27.5167	37,910	D
Common Shares	07/07/2026		A		22(2)	A	$0	37,932	D(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common shares purchased by the Reporting Person pursuant to the U.K. Employee Stock Purchase Plan (the "ESPP").

2. Represents an award of matching common shares under the ESPP that will be eligible to vest in full on July 7, 2027, subject to the Reporting Person's continued service through such date.

3. All of the shares reported are held directly by the Reporting Person, except for 121 of the unvested ESPP shares which are held in an employee trust for the benefit of the Reporting Person.

	/s/ Andreas Costas Loucaides	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)